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Abstract
[PSI
+] yeast, containing the misfolded amyloid conformation of Sup35 prion, is cured by inactivation of Hsp104. There has
been controversy as to whether inactivation of Hsp104 by guanidine treatment or by overexpression of the dominant
negative Hsp104 mutant, Hsp104-2KT, cures [PSI
+] by the same mechanism– inhibition of the severing of the prion seeds.
Using live cell imaging of Sup35-GFP, overexpression of Hsp104-2KT caused the foci to increase in size, then decrease in
number, and finally disappear when the cells were cured, similar to that observed in cells cured by depletion of Hsp104. In
contrast, guanidine initially caused an increase in foci size but then the foci disappeared before the cells were cured. By
starving the yeast to make the foci visible in cells grown with guanidine, the number of cells with foci was found to correlate
exactly with the number of [PSI
+] cells, regardless of the curing method. Therefore, the fluorescent foci are the prion seeds
required for maintenance of [PSI
+] and inactivation of Hsp104 cures [PSI
+] by preventing severing of the prion seeds. During
curing with guanidine, the reduction in seed size is an Hsp104-dependent effect that cannot be explained by limited
severing of the seeds. Instead, in the presence of guanidine, Hsp104 retains an activity that trims or reduces the size of the
prion seeds by releasing Sup35 molecules that are unable to form new prion seeds. This Hsp104 activity may also occur in
propagating yeast.
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Introduction
Prions are infectious proteins that self-propagate by changing
from their normal folded form to a misfolded amyloid form. In
mammals, prions are implicated in various fatal neurodegenerative
diseases, such as scrapie in sheep, bovine spongiform encephalop-
athy in cattle, and Crueutzfeld-Jacob disease in humans. Prions
have also been found in the yeast Saccharomyces cerevisiae and in the
fungus Podospora anserina. Yeast prions have served as convenient
models to study the mechanism of prion propagation. The
misfolded yeast prion is transmitted as seeds from mother to
daughter during cell division, and these seeds then cause
conversion of the properly folded protein to the misfolded prion
form [1].
One of the best characterized yeast prions, [PSI
+], occurs when
the translation termination factor Sup35 is transformed into its
aggregated amyloid form. Sup35 has three domains, N, M, and C,
which are respectively an N-terminal Asn/Gln rich aggregation-
prone domain, a middle domain, and a C-terminal domain that
mediates translation termination. The [PSI
+] phenotype has
impaired termination of protein translation as opposed to the
[psi
-] phenotype in which Sup35 is present in its properly folded
form. Maintenance of [PSI
+] and other misfolded yeast prions
requires molecular chaperones, in particular Hsp104 [2,3].
Hsp104, a member of the triple-A ATPase family, is a hexameric
protein with two nucleotide binding domains (NBD1 and NBD2)
in each of its 6 molecular subunits [4]. Inactivation of its ATPase
activity, either by incubating yeast with 5 mM guanidine or by
overexpressing the dominant negative Hsp104 mutant (Hsp104-
2KT), with mutations in both of its NBD domains (K218T and
K620T), cures the prion phenotype [2,5,6,7].
One of the techniques that have been employed to understand
the role of Hsp104 in prion propagation is confocal microscopy.
Initially, the truncated Sup35 fluorescent fragment, NMG, was
used as a reporter of the [PSI
+] phenotype [7,8,9,10,11]. NMG is
diffusive in [psi
-] yeast, whereas it forms fluorescent foci in [PSI
+]
yeast. However, NMG does not retain the functional properties of
the parent molecule. More recently, Sup35 has been engineered
with a GFP inserted between its N- and M- domains to produce
NGMC [12,13], which still retains both the functional and
conformational integrity of the parent molecule. Similar to NMG,
NGMC appears diffusive in [psi
-] yeast and forms foci in [PSI
+]
yeast. Consistent with this difference in appearance, the diffusional
mobility of NGMC is much faster in [psi
-] than in [PSI
+] yeast
[12].
To understand the role of Hsp104 in prion propagation,
changes in both NMG and NGMC fluorescence have been
examined following inactivation of Hsp104 in [PSI
+] yeast. The
Chernoff laboratory observed that when NMG was expressed
from the SUP35 promoter on a centromeric plasmid, large
fluorescent NMG foci were observed when [PSI
+] was cured by
overexpressing Hsp104-2KT [7,14]. In contrast, during curing of
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+] by guanidine treatment, they observed that the NMG
fluorescence became diffusive [7]. Furthermore, curing of [PSI
+]
by overexpression of Hsp104-2KT was much faster than curing by
guanidine treatment [7,14]. Based on the differences in curing of
kinetics and NMG fluorescence, they concluded that guanidine
treatment cures [PSI
+] by a different mechanism than over-
expression of Hsp104-2KT. In contrast, Tuite and coworkers
found that inactivation of Hsp104 by guanidine treatment or
overexpression of Hsp104-2KT cured [PSI
+] with similar kinetics
[15,16]. On this basis, they proposed a model in which
inactivation of Hsp104 either by guanidine treatment or by
overexpression of Hsp104-2KT inhibits severing, which in turn
prevents generation of new seeds. Curing of prion then occurs
when the seeds are diluted out by cell division [15,16,17,18].
Two recent microscopy studies have shown a defect in the
transmission of prion seeds from mother to daughter during the
curing of [PSI
+] by guanidine treatment. This defect in trans-
mission was observed either when NGMC was expressed from the
MFA1 promoter [19] or when NMG was expressed from the GAL1
promoter [20]. In contrast, results from our laboratory using
NGMC expressed from the SUP35 promoter showed that during
curing by guanidine treatment, the NGMC foci became diffusive,
acquiring mobility similar to their mobility in [psi
-] yeast even
though the yeast were still [PSI
+] [21].
In the present study, we reinvestigated the changes in NGMC
fluorescence that occur when [PSI
+] yeast were cured either by
overexpression of Hsp104-2KT or by guanidine treatment to
better understand the role of Hsp104 in prion propagation. Our
data showed that even though the seeds appeared to become much
smaller during curing by guanidine treatment than by over-
expression of Hsp104-2KT, the number of cells with foci
correlated exactly with the number of [PSI
+] cells regardless of
the method of curing. These results showed that the NGMC
fluorescent foci are indeed the prion seeds that maintain [PSI
+]
and curing occurs because of inhibition of the severing activity of
Hsp104. In addition, when [PSI
+] was cured by depleting the yeast
of Hsp104, the NGMC foci remained prominent, which
establishes that the loss of detectable foci during guanidine
treatment is due to an Hsp104-dependent activity. Measurements
of the seed size showed that the loss of detectable seeds occurred
because the seeds became much smaller during the curing of
[PSI
+] by guanidine treatment than by overexpression of Hsp104-
2KT. Therefore, our data are consistent with the thesis that during
curing by guanidine treatment, Hsp104 retains an activity that
reduces the size of the seed without changing their number of
seeds.
Materials and Methods
Yeast Strains, Plasmid, Media, and Growth Conditions
The 1074 [PSI
+] yeast strain, used routinely throughout this
study, has SUP35-GFP (NGMC) integrated into the genomic locus
of SUP35. This strain was derived from wild-type strain 779-6A
(MATa, kar1-1, SUQ5, ade2-1, his3D202, leu2D1, trp1D63, ura3-52)
[6]. The L2885 yeast strain (MATa, kar1-1, SUQ5, ade2-1,
his3D202. trp1D63, ura3-52, leu2-3, 112, sup35::SUP35-GFP)i s
a weak [PSI
+][ pin
-] strain derived from 74-D694 strain (strain
from S. Liebman, Univ. of Illinois) [22]. Plasmid pFL39-GAL-
HSP1042KT [7], which is a TRP1-based centromeric plasmid and
has HSP104 containing two amino acid mutations (K218T and
K620T) under the control of GAL1 promoter, was transformed
into these strains as described [23]. Single point mutants of
Hsp104, Hsp104(K218T) and Hsp104(K620T), were expressed
under the control of GAL1 promoter in yeast transformed with
either pRS314-GAL1-HSP104(K218T) or pRS314-GAL1-
HSP104(K620T). Plasmid pRS314-GAL1-SSA1 contains the
SSA1 coding region with its terminator region (287 bp) fused to
GAL1 promoter. GFP on a centromeric plasmid pJ543 was
expressed by the SUP35 promoter in the 779-6A strain.
The HSP104 gene was conditionally deleted by using the FLP-
FRT recombination system [24]. PCR amplified BamHI-XhoI
HSP104 fragment was cloned in pRS315 to generate pRS315-
FRT-HSP104. The plasmid pRS314-GAL1-FLP was generated
by cloning of XhoI-SacI fragment from the plasmid pC5GAL1-FLP
into pRS314. All sequences have been verified. Under non-
inducing condition of Flp recombinase, the yeast hsp104 deletion
(Dhsp104) strain derived from 1074 with plasmids pRS315-FRT-
HSP104 and pRS314-GAL1-FLP was able to maintain [PSI
+]a s
well as the Dhsp104 strain with the wild type copy of HSP104 on
centromeric plasmid pJ312 [25]. The Hsp104 protein level in the
latter strains was the same as the endogenous level.
Yeasts were grown at 30uC on synthetic defined medium (SD;
0.7% yeast nitrogen base, 2% glucose) with complete supplement
mixture (CSM) or the appropriate amino acid dropout complete
supplement mixture for selection and maintenance of the
particular plasmid. Synthetic galactose (SGal) medium contains
both 2% galactose and 2% raffinose in place of glucose. KYPD
solid medium used in the plating assays contains 0.5% yeast
extract, 2% peptone, and 2% glucose. Yeast were grown in
synthetic medium rather than yeast peptone medium since the
latter medium had background fluorescence that interfered with
imaging NGMC. Cultures were always maintained in active
growing conditions (OD600#0.6) by periodic dilution with fresh
medium.
Curing Experiments
To express the different mutants of Hsp104, cells from growing
culture in SD medium were shifted to SGal medium and
continued to grow until curing of [PSI
+] prion. Cells were grown
in the presence of 5 mM guanidine hydrochloride (Sigma, St.
Louis) to cure [PSI
+] either in SD or SGal, as indicated. Yeast were
grown in SGal to induce expression of the different Hsp104
mutants and Flp recombinase. To determine the extent of curing,
yeast were plated on KYPD plates as described previously [21].
Colonies with any white sectors were counted as [PSI
+].
Confocal Microscopy and Foci Counting
Cells were imaged on a Zeiss live confocal microscope using
a piezoelectric stage to obtain Z-stacks with a 100X objective in
8-well 25-mm
2 chambered coverslips (Lab-Tek, Rochester). The
same confocal settings were used for all images. To count cells
with foci and number of foci in a cell, cells at indicated
generations were fixed in 4% paraformaldehyde (PFA) (Sigma,
St. Louis) in phosphate buffer saline for 5 min at room
temperature, followed by acquiring Z-stack images (16 slices at
0.4 mm intervals). In order to count the foci in cells grown with
5 mM guanidine, cells were either incubated for 1 h in water or
for 1–1.5 h in SGal medium to induce expression of Hsp104-
2KT. To image bud scars, cells were stained with 2 mg/ml
Alexa Fluor 647 conjugated wheat germ agglutinin (WGA) from
Invitrogen for 20 min at room temperature. The transmission of
the prion NGMC foci from mother into daughter cells was
imaged using a Zeiss confocal microscope LSM780. Daughter
cells were photo-bleached for 5 s before monitoring. Imaging
was always performed on log phase yeast cells (OD600#0.6) to
prevent the development of fluorescent vacuoles, which can be
confused with fluorescent foci.
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To determine the prion phenotype of the progeny originating
from individual cells, a 0.5 ml drop of yeast suspension
(OD600=0.01) was added to a well of a glass bottomed 96 well-
plate (MatTek, Ashland, MA). The drop was then scanned to
determine the number of cells per drop and the number of foci per
yeast cell. Following scanning, drops with single cells were either
directly transferred onto KYPD plates or first grown for 14 h in
200 ml SD medium prior to plating.
Western Blot Analysis
Cell lysis and Western blotting were performed as described
previously with minor modifications [26]. When cells in an actively
growing culture reached an OD600 of 0.6–0.65 were collected and
suspended in an equal volume of lysis buffer (50 mM Tris-HCl,
pH 7.4,200 mMNaCl,0.5 mMEDTA,pH 8.0,0.5 mMDTT,and
onetabletofaproteaseinhibitorcocktail(Roche,Indianapolis,IN)in
4 ml volume of buffer, and broken with 0.5 mm glass beads using
a mini-bead beater (Biospec Products, Bartlesville OK). After
removing cell debris, the total lysate was fractionated by ultracen-
trifugation at 100,000 rpm for 15 min at 4uC with a TL100
centrifuge (Beckman, CA) and the supernatant was recovered.
Identical volumes wereloadedon 10%SDS-PAGE gels. Proteinsin
the gels were transferred to a nitrocellulose membrane (Invitrogen,
Carlsbad, CA) by using a wet blotting system (Bio-Rad, Hercules,
CA). The following antibodies were used: anti-GFP polyclonal
antibody (Abcam), anti-Pgk1 monoclonal antibody (Molecular
Probes,Carlsbad,CA)andanti-Hsp104polyclonal(Abcam).Native
Sup35 was detected using a polyclonal rabbit anti-Sup35 antibody
made in our laboratory. Hsp70 expression level was detected by
monoclonal anti-Hsp70 antibody (Stressgen). Odyssey dye 800-
conjugatedgoatanti-rabbitordonkeyanti-mouseantibodywasused
assecondaryantibody.Odysseyscannerandsoftwarehavebeenused
fordetectionofbandsandquantitationoftheintensityofbandsonthe
blots represented infigures.
Fluorescence Correlation Spectroscopy Measurements
and Data Analysis
Fluorescence correlation spectroscopy (FCS) was carried out
using the Zeiss ConfoCor system (Thornwood, NY) using an
Apochromat 40X/1.2W objective, a 488-nm laser, a 505–550 nm
bandpass and a pinhole width of 1 Airy unit. FCS measurements
were performed by averaging of 20 consecutive measurements of
1 s for cell measurements and 10 consecutive measurements of
10 s for lysate measurements. Rhodamine 6G (Sigma) was used to
calibrate the observation volume. Recombinant GFP (gift G.
Patterson, NIH) was used to measure the diffusion coefficient of
GFP in solution. For each measurement, a minimum of 10 cells
were measured at a given experimental condition. Each experi-
mental condition was repeated a minimum of 5 times and the
results of the individual experiments were then averaged. The
calculation of the autocorrelation functions was performed during
the measurement using the ConfoCor software. The autocorrela-
tion function, G(t) was fitted to the model as follows:
G(t)~
I(t)I(tzt)
½I(t) 
2
where I(t+t) is the fluorescence intensity obtained by the single
photon counting method in a detection volume at a delay time t
(brackets denote an ensemble average). The autocorrelation curves
were fitted using a one-component fit, i.e. assuming only one class
of species, unless specified otherwise. For the fits, the deviation
plots showed that the one-component fit was compatible with the
data.
Results
Curing of [PSI
+] Prion by Overexpression of Dominant
Negative Hsp104 Mutant
The fluorescence of NGMC was first imaged during the curing
of [PSI
+] yeast by overexpression of the Hsp104 dominant negative
mutant, Hsp104-2KT. The 1074 yeast strain with NGMC
integrated into the genomic SUP35 locus was used to express
NGMC at the endogenous Sup35 level. Starting with [PSI
+] yeast,
we clearly detected NGMC foci when [PSI
+] yeast were scanned
using the Zeiss live confocal microscope. When Hsp104-2KT was
induced by galactose, the foci became much more prominent after
growing 1.5 h in SGal (Fig. 1A). As noted previously, this change
in brightness of the NGMC foci occurred upon changing the
medium from SD to SGal, whereas a similar change in media had
no effect on the diffusive appearance of NGMC in [psi
-] yeast [27].
This brightening of the fluorescent foci due to the change in
medium only lasted several hours until the cells adapted to the new
growth condition. Similarly, the foci became more prominent
when yeast were incubated in water, which was also reversed upon
returning the yeast to SD medium [27].
In contrast to the transient brightening due to the change of
medium, the foci remained prominent with continued expression
of Hsp104-2KT. As curing occurred, there was a progressive
reduction in foci number and a concomitant increase in cytosolic
NGMC (Fig. 1A). Ultimately, the NGMC became totally diffusive
at which point the yeast were presumably [psi
-]. To determine the
relationship between the number of cells with foci and the number
of cured cells at different generation times, the yeast cells were
either plated to assay prion phenotype by using the red/white
colony count or fixed and imaged using Z-stack confocal scanning.
From these data, the percentage of cells with foci and the
percentage of [PSI
+] cells were plotted as a function of generation
time (Fig. 1B). The curves show a similar trend, but at a given
generation time, there were more cured cells than cells lacking
foci.
Since cells with foci are expected to be [PSI
+], we examined
whether the difference between the curves in Fig. 1B was caused
by cells with a few foci giving rise to progeny that were [psi
-] on the
plate. To test this, Z-stack confocal images of individual cells were
obtained following 9 generations of Hsp104-2KT expression.
These scanned cells were then plated to determine the prion
phenotype. From this analysis, cells without foci (n=71) yielded
red colonies indicating [psi
-] prion phenotype, while cells with
three or more foci (n=33) yielded white or white-red sectored
colonies, indicating [PSI
+] prion phenotype. However, 74% of the
cells with only one focus (n=27) and 27% of the cells with two foci
(n=26) gave rise to red colonies, indicating that the progeny of
these [PSI
+] cells were [psi
-]. This in turn suggested that curing
might be occurring on the plate after Hsp104-2KT expression was
turned off, but before the remaining Hsp104-2KT was diluted out
by cell division, as was proposed by Ferreira et al [15]. Indeed,
when cells with a single focus were omitted from the data set, there
was excellent agreement between the percentage of cells with more
than one focus and the percentage of cells that were [PSI
+] (Fig. 1B,
open and closed circles). This suggests that the visible foci are, in
fact, the prion seeds with the possible exception of the single focus.
To confirm that the single focus is actually a prion seed rather
than a dead end aggregate, individual yeast cells with only one
visible NGMC focus were cultured overnight in glucose medium
and then plated. We observed that these cells (n=11) always
Curing of [PSI+] Prion by Hsp104 Inactivation
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white-red sectored, which showed that the single focus was indeed
a prion seed. In addition to the white or white-red colonies, many
of the daughter cells formed red colonies, indicating that inhibition
of severing by Hsp104-2KT persisted for several generations until
the Hsp104-2KT was finally diluted out. It is this persistence of
Hsp104-2KT that causes yeast with a single focus to produce
many daughter cells that are [psi
-].
Next, we examined whether the number of fluorescent foci is
halved each generation when [PSI
+] was cured by overexpression
of Hsp104-2KT as predicted by the cell division model of Tuite
and coworkers [16,18]; this model predicts that inhibition of
Hsp104 activity cures prion by inhibiting severing of the prion
seeds so that the seeds are diluted out by cell division. To test this
prediction, the average number of foci per cell was counted at
different generation times during the late stages of prion curing.
The semi-log plot of these data (Fig. 1C) shows halving of the
average number of foci from generation to generation, in
agreement with the results of Cox et al. [28]. These results again
indicate that the visible foci are the prion seeds.
The imaging of NGMC foci also provides a method to
determine the number of NGMC molecules per focus provided
that we can count the number of foci in each yeast cell. Since we
could not clearly resolve the individual foci in [PSI
+] cells, the
number of foci was counted in [PSI
+] cells after 2 h of Hsp104-
2KT induction. At this time the foci had become pronounced, but
the yeast had not yet divided in the SGal medium. After fixing the
cells, a value of 220616 (n=18) foci per cell was counted from
the Z-stack confocal images, which is in good agreement with the
number of foci that were derived from the curing curve [28].
Knowing the average number of foci per cell, the number of
Sup35 molecules in a focus was calculated to be 360, based on the
measured value of 80,000 Sup35 molecules per cell [29].
The transmission of foci from mother to daughter was also
examined to determine whether the daughter cells inherited 40%
of the total foci with the mother cells retaining 60%. This ratio is
based on the seeds segregating with equal probability between the
mother and daughter cells when corrected for the volume
difference between mother and daughter cells [30]. Following
overexpression of Hsp104-2KT for 4 and 5 generations, [PSI
+]
cells were fixed and bud scars were stained. Daughter cells in the
population were identified by the faint staining birth scar. The
NGMC foci per cell were counted in daughter cells and in mother
cells with either 2 or 3 bud scars. Table 1 shows that the ratio of
foci between daughter and mother cells was 2:3, as predicted by
Byrne et al. [30]. In addition, to monitoring the distribution of
NGMC foci between mother and daughter cells, live cell imaging
was used to follow the transmission of the NGMC foci from
mother to daughter cell after expressing Hsp104-2KT for 6–7
generations. Movie S1 shows the transmission of NGMC foci from
a mother to a daughter cell, which is representative of more than
20 budding yeast that were imaged. The NGMC foci readily
Figure 1. Curing of [PSI
+] by overexpression of Hsp104-2KT. (A) Change in fluorescence of NGMC during curing of [PSI
+] by overexpression of
Hsp104-2KT. Cells having pFL39-GAL-HSP104KT grown in SD (0 h) were shifted into SGal and incubated until [PSI
+] seeds were eliminated.
Fluorescent images show NGMC in yeast at the indicated growth time (h) or generations (g) from one slice of a Z-stack (16 slides, interval 0.4 mm). (B)
Correlation between [PSI
+] cells and cells with foci. Curing of [PSI
+] prion was determined at the indicated generations from the red/white colony
count of cells plated on KYPD plates. The number of cells with foci was counted from Z-stacks of confocal images of fixed cells. Three different
experiments yielded similar results. (C) Semi-log plot of average number of foci per cell during curing. For each generation time point, the number of
foci was counted in 300–400 cells from Z-stack confocal images of fixed cells. Using the initial data point of 5.5 average foci number at 5.6
generations, the theoretical dashed line was calculated by halving the average foci number at each cell division.
doi:10.1371/journal.pone.0037692.g001
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2KT, which is consistent with the foci ratio in Table 1. Under
these conditions, we do not see a defect in transmission as has been
observed in [PSI
+] yeast with active Hsp104 [31].
Residual Hsp104 Activity in the Presence of Guanidine
Although the above data establish that the visible foci are the
prion seeds, this conclusion appears to contradict our previous
result that when [PSI
+] was cured by guanidine, the NGMC
fluorescence became diffusive even though the cells were not yet
cured [21]. These earlier results are confirmed by the images in
Fig. 2A, which show the fluorescence of NGMC in yeast during
curing of [PSI
+] by guanidine. In agreement with our previous
study [21], after addition of guanidine the foci first became
brighter and then disappeared so that after 3–4 generations, the
NGMC fluorescence appeared completely diffusive in all of the
cells, indistinguishable from the fluorescence of [psi
-] yeast even
though the cells were all [PSI
+] based on the colorimetric colony
assay. Interestingly, if curing of [PSI
+] were done in SGal medium
to induce expression of Hsp104-2KT, as well as 5 mM guanidine,
the NGMC foci remained bright, but this did not occur in control
cells with an empty vector when these cells were cured in SGal
medium with 5 mM guanidine (Fig. 2B). Based on these results, we
conclude that the loss of detectable foci during curing of [PSI
+]
yeast by guanidine is blocked by overexpression of Hsp104-2KT.
Since foci were prominent during curing of [PSI
+] yeast by
Hsp104-2KT, but not by guanidine treatment, we wanted to
determine whether prominent NGMC foci also occurred in the
absence of Hsp104. To examine the effect of Hsp104 depletion on
NGMC fluorescence, [PSI
+] yeast were cured by conditionally
deleting the HSP104 gene using the FLP/FRT recombination
system. For this experiment, we used a Dhsp104 strain of [PSI
+]
yeast transformed with pRS315-FRT-HSP104 and pRS314-
GAL1-FLP plasmids (see Materials and Methods). When these
yeast were grown in SGal medium to induce expression of Flp
recombinase, this produced excision of the HSP104 gene. Western
blot analysis showed that the level of Hsp104 in the yeast
population was 48% and 23% of the control value after 10 and 15
generations in SGal medium, respectively, and by 21 generations,
essentially all of the Hsp104 protein was depleted from the yeast
cells (Fig. 2C). The fact that the level of Hsp104 is not halving each
generation indicates that HSP104 excision is occurring over many
generations in the yeast population.
Fluorescent imaging of the yeast cells showed that after 10
generations in SGal medium to induce Flp recombinase expres-
sion, more than 90% of the cells still had prominent foci (Fig. 2D)
and with further divisions, the number of foci per cell decreased
and gradually all of the NGMC became diffusive, characteristic of
[psi
-]. Therefore, depletion of Hsp104 produces a similar effect on
the NGMC foci as expression of Hsp104-2KT. Furthermore,
when cells were first grown for 10 generations in SGal medium to
excise HSP104 and then incubated further for another 5
generations with guanidine, the remaining foci still appeared very
prominent (Fig. 2D, panel c), no different from cells grown in the
absence of guanidine (Fig. 2D, panel d). Furthermore, there was
no significant change in the number of cells with foci or the foci
intensity when the cells were placed in water for 1 h (Fig. 2D,
panel e). Therefore, the NGMC foci do not become diffusive in
the presence of guanidine in the absence of Hsp104, which
confirms that Hsp104 is responsible for the loss of detectable
NGMC foci during curing of [PSI
+] by guanidine.
Relationship between the Foci and the Seeds During
Curing by Guanidine
Since the foci are made prominent during curing of [PSI
+]b y
guanidine by transient incubation in water or in SGal to induce
expression of Hsp104-2KT, we used these methods to further
confirm that the foci are the seeds. At different time points during
[PSI
+] curing by guanidine, aliquots of cells were plated to
determine the prion phenotype, while other aliquots were grown
in SGal medium for 1.5 h to induce Hsp104-2KT. As shown in
Fig. 3A, the analysis of colony color and the fluorescent images
showed that the percentage of cells that are [PSI
+] and the
percentage of cells with foci were essentially identical. The same
results were obtained when the partially cured cells were placed in
water for 1 h prior to imaging to increase the intensity of the foci.
In contrast to curing by overexpression of Hsp104-2KT, there
was excellent agreement between the percent [PSI
+] cells and the
percent cells with foci without having to correct the data for cells
with a single focus since guanidine is immediately removed from
the yeast upon plating. This was confirmed by determining that
the cells with a single focus had a [PSI
+] phenotype after plating.
Specifically, after growing [PSI
+] cells for 9 generations with
guanidine, the cells were placed in water for 1 h. Z-stack scanning
and the plating of individual cells showed that cells without foci
(n=36) formed red colonies, while cells with one (n=15) or more
foci (n=17) formed white or occasionally white-red sectored
colonies. Therefore, the foci are indeed the prion seeds, although
the seeds do not always have to be visible as foci.
Previously the absence of visible foci in yeast incubated with
guanidine led us to incorrectly propose that when cells were cured
by guanidine, the number of seeds was actually reduced without
cell division [21]. Experiments in which cell division was blocked
by alpha factor seemed to corroborate this conclusion since when
cells were grown with alpha factor for more than one day, cured
cells appeared. In fact, it turned out that our results were caused
by the combination of cells resistant to alpha factor that continued
to divide in the presence of alpha factor and toxicity caused by
alpha factor in the non resistant cells [18]. Therefore, although the
foci are not detectable during curing by guanidine, only cell
division actually reduces the number of seeds.
Table 1. Distribution of foci between daughter and mother cells*.
Generations # of foci Daughter cells
a # of foci Mother cells
b Ratio (daughter : mother)
4 14 (N=70) 21.5 (N=61) 0.42: 0.58
5 7.2 (N=61) 11.6 (N=71) 0.39: 0.61
*Foci were counted in cells having plasmid pFL39-GAL-HSP104KT. The cells were grown for 4 and 5 generations in SGal before to fixing and staining with WGA. N
indicates the counted cell number.
aDaughter cells were identified by the faint staining birth scar.
bMother cells with 2–3 bud scars were used in counting NGMC foci.
doi:10.1371/journal.pone.0037692.t001
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generation during the curing of [PSI
+] by guanidine. After growing
the yeast for 5 or more generations in the presence of guanidine,
the yeast were starved for 1 h in water prior to fixation to enable
detection of the foci. By imaging confocal Z-stacks of the fixed
cells, we determined the average number of foci as a function of
generation time. In agreement with Cox et al. [28], the number of
foci decreased with increasing generation time, but as shown by
semi-log plot of average foci number per cell versus generation
time, the data deviated from the theoretical line calculated on the
basis of the foci halving each generation (Fig. 3B). As pointed out
by Byrne et al [18], this deviation could be due to guanidine not
completely inhibiting the severing activity of Hsp104. In fact, the
deviation from the theoretical line is consistent with 20% of the
existing seeds being severed at each generation. This amount of
severing would also account for the observation that the curing of
[PSI
+] by guanidine lags by 2–3 generations compared to the
curing by overexpression of Hsp104-2KT. Therefore, Hsp104
appears to retain some residual severing activity in 5 mM
guanidine, in contrast to the complete inhibition of severing
activity observed upon overexpression of Hsp104-2KT.
To further check that this residual severing activity does not
account for the loss of detectable foci during curing by guanidine,
we repeatedly imaged the foci during the final stages of curing.
After 5 generations of growing [PSI
+] yeast with guanidine, at
which time the cells all showed diffuse fluorescence but still were
[PSI
+], the yeast were incubated in water for 1 h to make the foci
prominent. The yeast were returned to SD medium with
guanidine, which again caused diffuse fluorescence and further
curing. At different time points during the curing cycle, the cells
were incubated in water for 1 h, followed by Z-stack confocal
microscopy. The maximum Z-stack projections of the yeast cells
imaged at indicated generations in Fig. 3D show a marked
reduction in the number of foci. Along with this reduction in foci
number, there is, as expected, a reduction in the number of cells
with foci (Fig. 3C). Importantly, severing could only cause all of
the seeds to become undetectable if all of the seeds, not just 20%
were severed. If this were the case, then there would not have been
a steady reduction in foci number as the cells divided. The fact
that the number of seeds markedly decreased shows that severing
is not causing the loss of detectable foci. Therefore these results
confirm that the loss of detectable foci is not due to the residual
severing activity of Hsp104.
Factors that Affect the Fluorescence of NGMC Foci
during Curing of [PSI
+]
The Hsp104-2KT mutant has point mutations at the active sites
of both NBD1 (K218T) and NBD2 (K620T), whereas it has been
suggested that guanidine inhibits the activity of just the NBD1
domain [32]. This led us to specifically inactivate the NBD1
domain of Hsp104; biochemical studies showed that mutating the
active site of NBD1 essentially eliminated the ATPase activity of
Figure 2. Effect of guanidine on fluorescence of NGMC foci in [PSI
+] yeast in presence and absence of Hsp104. (A) Change in
fluorescence of NGMC during curing by guanidine. Cells were grown in SD with 5 mM guanidine for the indicated growth time in hours (h) or
generations (g). (B) Fluorescent imaging of [PSI
+] cells either with the empty vector (a) or plasmid pFL39-GAL-HSP104KT expressing Hsp104-2KT (b)
were grown for 5 generations in SGal with 5 mM guanidine. (C) Western blot analysis of Hsp104 to determine the level of Hsp104 following excision
of Hsp104 after inducing expression of Flp recombinase. Yeast were grown in SGal to induce expression of Flp recombinase to delete the FRT-sites
flanked HSP104. Lysates were obtained from the conditional deletion yeast strain of HSP104 grown in SD (lane 1) and SGal for indicated generations
(lane2–5), and the Dhsp104 strain (lane 6). The percent Hsp104 calculated from the intensity at each time relative to the intensity of the control was
corrected for protein loading using the Pgk1 standard. (D) Fluorescent microscopic images of yeast expressing NGMC before and after conditional
deletion of HSP104. The conditional deletion yeast strain of HSP104 was grown in SD (a) or in SGal for 10 generations (b), followed by another 5
generations in SGal with (c) and without (d) 5 mM guanidine. Cells in panel (d) were incubated for 1 h in water (e). Images show one slice from a Z-
stack (16 slides, interval 0.4 mm).
doi:10.1371/journal.pone.0037692.g002
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Interestingly, when [PSI
+] was cured by overexpression of
Hsp104(K218T), just as occurred during curing by guanidine,
the NGMC foci became undetectable in the majority of the cells
even though the cells were still [PSI
+] (Fig. 4A). Along with the loss
of detectable foci, the rate of curing by overexpression of
Hsp104(K218T) was slightly delayed compared to the rate of
curing by overexpression of the Hsp104-2KT. The time course
of curing by overexpression of Hsp104(K218T) was the same as
that observed during curing by guanidine. These results show that
that Hsp104(K218T) has limited severing activity, which in turn
shows that the NBD2 domain of Hsp104 also contributes to the
severing activity of Hsp104. Therefore, the Hsp104(K218T)
mutant has markedly reduced severing activity but retains
a residual activity that apparently leads to the loss of detectable
foci, similar to the effect of guanidine treatment on Hsp104
activity Evidently, complete inhibition of Hsp104 activity requires
mutating the active sites of both NBD1 and NBD2.
If guanidine is curing solely by inactivating the NBD1 domain
of Hsp104, then guanidine should have no effect on the curing of
[PSI
+] by overexpression of Hsp104(K218T). However, addition
of guanidine caused faster curing of [PSI
+] by Hsp104(K218T)
(Fig. 4B). Specifically, the rate of curing increased by about 2
generations, which shows that guanidine is not just inactivating the
NBD1 domain. In fact, the time course of [PSI
+] curing by the
combination of overexpression of Hsp104(K218T) and 5 mM
Figure 3. Curing of [PSI
+] by guanidine. (A) Correlation between cells with foci and [PSI
+] yeast as a function of generation time during curing by
guanidine. The kinetics of [PSI
+] curing was measured by plating yeast at indicated generations on KYPD plates. Yeast having plasmid pFL39-GAL-
HSP104KT were grown in SD with 5 mM guanidine. To visualize the foci during curing, cells were incubated at indicated generations either in SGal for
1.5 h to express of Hsp104-2KT or in water for 1 h. The number of cells with foci was counted from Z-stacks of confocal images of fixed cells. Three
different experiments yielded similar results. (B) Semi-log plot of average number of foci per cell during curing of [PSI
+] by guanidine. For each
generation time point, the number of foci was counted in 300–400 fixed cells from Z-stacks of confocal images of fixed cells. Using the initial data
point of 4.1 average foci number at 5.6 generations, the theoretical dashed line was calculated by halving the average foci number at each cell
division. (C) Curing and fluorescent images of NGMC in yeast during final stages of curing by guanidine. [PSI
+] yeast grown for ca. 5 generations in SD
with 5 mM guanidine were incubated in water for 1 h to visualize foci, and then the yeast were returned to SD with 5 mM guanidine and incubated
further for 7–8 generations. At indicated generations, cells were incubated in water for 1 h and imaged by Z-stack confocal microscopy. Two different
experiments are shown. (D) Imaging of the NGMC foci during the late stages of curing of [PSI
+] by guanidine. The maximum Z-stack projections of the
yeast cells are shown before (a-d) and after incubation in water for 1 h (a9-d9). Cells were imaged in experiment #2 in (C), where a-d shows the
indicated generation.
doi:10.1371/journal.pone.0037692.g003
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+] by overexpression of either Hsp104(K218T) or Hsp104(K620T). (A) Fluorescent images of NGMC were from
partially cured [PSI
+] yeast grown in SGal to induce overexpression of Hsp104(K218T) for 7.5 generations (a), followed by incubation in water for 1 h
(a*). Fluorescent images of NGMC were from yeast grown for 5.5 generations in SGal to induce overexpression of Hsp104(K218T) in the presence of
5 mM guanidine (Gdn) (b), followed by incubation in water for 1 h in water (b*). (B) Kinetics of [PSI
+] curing by overexpression of Hsp104(K218T) and
by overexpression of Hsp104(K620T). The curing of [PSI
+] either by overexpression of Hsp104(K218T) without (open circles) and with guanidine
(closed triangles) or by overexpression of Hsp104(K620T) (closed circles) was plotted as a function of generation time. For comparison, the curing
curves of [PSI
+] strain by overexpression of Hsp104-2KT and by guanidine are shown by the dotted and dashed lines, respectively. (C) Fluorescent
images of [PSI
+] yeast partially cured by overexpression of Hsp104(K620T) for 3 and 9 generations.
doi:10.1371/journal.pone.0037692.g004
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+]
was cured by overexpression of Hsp104-2KT. Therefore, this
combination essentially eliminated the severing activity of Hsp104.
At the same time, NGMC foci were not visible in cells that were
still [PSI
+] (Fig. 4A), which results rule out that limited severing
activity produces the loss of detectable NGMC foci.
The above results predict that the NBD2 domain of Hsp104 is
acting to make the NGMC foci undetectable during curing. To
test this prediction, we expressed Hsp104(K620T), which contains
a point mutation only at the active site of the NBD2 domain of
Hsp104. After inducing Hsp104(K620T) expression by galactose
in [PSI
+] yeast, the cells were imaged and plated on K YPD plates.
In agreement with the prediction, prominent foci were still present
both at 3 and 8 generations after induction of Hsp104(K620T)
(Fig. 4C). Fig. 4B shows that overexpression of Hsp104(K620T)
cured [PSI
+] yeast, but at a much slower rate than overexpression
of either Hsp104-2KT or Hsp104(K218T). Therefore, the NBD2
domain, as well as the NBD1 domain of Hsp104, functions in the
severing activity of Hsp104, but the NBD1 domain appears to
have a greater severing activity than the NBD1 domain. This
difference in severing activity between the NBD domains of
Hsp104 has the caveat that there may be less hexameric
Hsp104(K620T) compared to Hsp104(K218T) in the yeast cytosol
based on in vitro studies showing that the Hsp104(K620T) mutant
has impaired oligomerization [33].
We also examined whether the decrease in fluorescence
intensity of the seeds during curing of [PSI
+] by guanidine is
dependent on the yeast strain by using the L2885 yeast strain
derived from the wild-type strain 74-D694 [22]. This strain
expresses NGMC from the SUP35 genomic locus using the
NGMC construct engineered in the Serio laboratory [13]. Both
the change in fluorescence and the prion phenotype were
monitored in the L2885 strain during curing of [PSI
+] either by
overexpression of Hsp104-2KT or by guanidine treatment. With
this strain, there were also prominent foci in cells grown for 6
generations in SGal to overexpress Hsp104-2KT as compared to
the absence of detectable foci in yeast grown in 5 mM guanidine
(Fig. 5A). Under the latter conditions, the foci again became visible
when the cells were incubated in water (Fig. 5A, panel c). Fig. 5B
shows that the kinetics of [PSI
+] curing in the L2885 strain when
Hsp104 was inactivated either by overexpression of Hsp104-2KT
or by guanidine were similar to the kinetics of [PSI
+] curing in the
1074 strain. Therefore, regardless of the yeast strain, there is
a decrease in the fluorescence intensity of the seeds when [PSI
+]i s
cured by guanidine as opposed to overexpression of Hsp104-2KT.
Since Ssa1 has been shown to antagonize the action of Hsp104
[34], we examined the effect of Ssa1 overexpression on the curing
of [PSI
+] by guanidine. Ssa1 under the control of the GAL1
promoter was expressed by growing yeast in SGal medium, which
doubled the expression level of Ssa1 (Fig. 6A). Compared to the
empty vector controls grown in SGal medium (Fig. 6B, panel a),
overexpression of Ssa1 caused an increase in the brightness of the
NGMC foci in [PSI
+] yeast (Fig. 6B, panel c), as shown previously
with the L2885 strain [22]. However, in contrast to the L2885
strain, overexpression of Ssa1 did not cure [PSI
+] in the 1074 yeast
strain even when expressed for 20 generations (Fig. 6C), indicating
that severing is not inhibited. Imaging of the NGMC fluorescence
in yeast overexpressing Ssa1 showed marked variability in the
brightness of the foci possibly due to severing creating a broad size
distribution of seeds. When Ssa1 was overexpressed during the
curing of [PSI
+] by guanidine treatment, the NGMC foci did not
become undetectable, but rather were clearly visible until the yeast
were cured (Fig. 6B, panel d), whereas the empty vector control
did not show detectable foci (Fig. 6B,b). Even though the NGMC
foci were visible until the cells were cured, overexpression of Ssa1
did not effect on the kinetics of [PSI
+] curing (Fig. 6C), which
again indicates that Ssa1 does not affect severing. These
observations suggest that increased expression of Ssa1 antagonizes
the activity of Hsp104 that renders the foci undetectable by
fluorescence imaging during the curing of [PSI
+] by guanidine
treatment.
Diffusional Mobility of NGMC in [psi
-], [PSI
+] and Partially
Cured [PSI
+] Yeast
To determine whether the size of the NGMC foci are reduced
during the curing of [PSI
+] by guanidine, as suggested by the
observation that the NGMC foci became undetectable, we used
FCS to measure the diffusional mobility of the seeds. First, we
measured the diffusional mobility of NGMC in [psi
-] and [PSI
+]
yeast; as a control we also measured the diffusional mobility of
GFP (Fig. 7). As expected, the autocorrelation curves showed that
NGMC had a much slower mobility in [PSI
+] than in [psi
-] yeast.
In addition, the diffusional mobility of NGMC became slower and
quite heterogeneous when Ssa1 was overexpressed. To analyze the
data more quantitatively, the autocorrelation curves were fitted
with a 1-component fit since essentially all of the Sup35 is soluble
in [psi
-] yeast and aggregated in [PSI
+] yeast. Both in [psi
-] and
[PSI
+] yeast, GFP had a dwell time of about 0.3 msec, which was
used to calculate a diffusion coefficient of 22 mm
2s
21 [35], in good
agreement with values from other laboratories [36,37]. NGMC
had dwell time of about 1.0 msec in [psi
-] yeast, as shown
previously [20], whereas the dwell time of NGMC was 2.5 msec in
[PSI
+] yeast.
Given the molecular weight of GFP, apparent molecular
weights were calculated using the proportionality that the
molecular weight scales with the cube of the dwell time for
globular proteins. On the basis, NGMC has an apparent
molecular weight of about 1000 kDa in [psi
-] yeast, which is
much greater than the molecular weight of Sup35, even if it forms
a 1:1 complex with Sup45. This high molecular weight is
consistent with Sup35 binding to ribosomes. As for the apparent
molecular weight of NGMC in [PSI
+] yeast, a value of about
14,000 kDa was determined. Based on one molecule of Ssa1/SSa2
binding to 2 molecules of Sup35 in the amyloid complex [38], this
implies that there are approximately 100 molecules of NGMC per
seed in [PSI
+] yeast.
We also measured the diffusional mobility of the NGMC foci
after 2 h of Hsp104-2KT induction, the same condition used
above to count the number of NGMC foci. As shown in Fig. 7,
NGMC had a slower mobility following induction of Hsp104-2KT
than it does in [PSI
+] yeast, consistent with the brighter NGMC
foci observed in cells expressing Hsp104-2KT. A value of about
5 msec was obtained by fitting the autocorrelation curve,
indicating that each focus has roughly 800 NGMC molecules
per seed calculated from the molecular weight of NGMC and
assuming that there is one molecule of Ssa1/Ssa1 bound to Sup35
in the amyloid fiber. This value of 800 molecules per seed is about
twice the value of 360 NGMC molecules per seed that was
calculated above by counting the number of foci per cell and the
value of 80,000 molecules of Sup35 per cell [29]. The approximate
2-fold difference in mass may be due to other proteins, in addition
to Ssa1/Ssa2, binding to the amyloid fibers as well as the
assumption, used to calculate the mass that the amyloid fiber had
a globular shape.
Next we compared the mobility of NGMC during curing of
[PSI
+] yeast by overexpression of Hsp104-2KT and curing by
guanidine treatment. This comparison was made at 3 generations,
the earliest time at which the foci became undetectable in the
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+] cells during curing by guanidine treatment.
Fig. 7 shows that the autocorrelation curves of NGMC were very
different for the two conditions. Specifically, the mobility of
NGMC in yeast overexpressing Hsp104-2KT was slower than in
[PSI
+] yeast, while the mobility of NGMC in guanidine-treated
yeast was faster than in [PSI
+] yeast. In fact, the mobility of
NGMC in guanidine-treated yeast is essentially the same as that of
NGMC in [psi
-] yeast.
To calculate the diffusional mobility of the seeds under these
variousconditions,weagainanalyzedthedatausinga1-component
fit for the autocorrelation curves. In lysates from [PSI
+] yeast
expressing Hsp104-2KT for 3 generations, there was no increase in
thesolubleNGMCfractioncomparedtolysatesform[PSI
+]yeastas
determined by Western blot analysis (Table 2). This indicates that
essentiallyallofNGMCisaggregated.Fittingoftheautocorrelation
curvesforNGMCinyeastexpressingHsp104-2KTfor3generations
yieldedadwelltimeofabout6 msec,whichindicatesthateachfocus
has roughly 1400 NGMC molecules per seed calculated from the
molecularweightofNGMCandtheassumptionthatoneSsa1/Ssa2
molecule bound per 2 Sup35 molecules in the amyloid fiber. This
increaseinthesizeoftheseedsfrom800Sup35moleculesperseedto
1600 molecules per seed between 2 and 3 generations is consistent
with the observed increase in brightness and suggests that newly
synthesizedNGMCboundtotheseedsratherthanbecomingsoluble.
As for determining the diffusional mobility of the seeds in [PSI
+]
yeasttreatedwithguanidinefor3generations,thedatawerefirstfitted
usinga1-componentfit,whichyieldedadwelltimeofabout1 msec,
indicatingamolecularweightof1000 KdafortheNGMCcomplex.
These same data were also fitted using a 2-component fit since the
yeastcytosolnotonlycontainssolubleNGMC,butalsoseeds,which
became visible upon transient expression of Hsp104-2KT or
incubation of the yeast in water. In fitting the data using a 2-
Figure 5. Curing of [PSI
+] by overexpression of Hsp104-2KT or by guanidine in strain L2885. (A) Fluorescence images of NGMC were from
partially cured L2885 [PSI
+] yeast grown for 6 generations either in SGal to induce overexpression of Hsp104-2KT (a) or in SD with 5 mM guanidine (b)
followed by 1 h incubation in water (c). (B) Kinetics of [PSI
+] curing by Hsp104 inactivation in strain L2885. The curing of [PSI
+] by overexpression of
Hsp104-2KT (closed circles) or by guanidine (open circles) is plotted as a function of generations. For comparison, the curing curves of [PSI
+] strain by
overexpression of Hsp104-2KT and by guanidine in strain 1074 are shown by the gray line and the gray dashed line, respectively.
doi:10.1371/journal.pone.0037692.g005
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1 msec,thevalueforsolubleNGMCmeasuredin[psi
-]yeast.Onthis
basis,morethan90%oftheNGMChadamobilityof1 msec,while
theslowercomponenthadadwelltimeofabout10 msec,indicating
a molecular weight for the NGMC complex of 900,000 kDa. Given
thatthepartiallycured[PSI
+]yeasthavemorethana100seedsbased
onthekineticsofcuring[18],itisnotpossibleforthishighmolecular
weight component represents the seeds. Instead, the highmolecular
weight component appears to be an immobilized NGMC fraction,
whichwasalsopreviouslyobserved[20],isalsopresentin[psi
-]yeast
when the autocorrelation curve of NGMC was fitted to a 2-
component fit with the sameparameters. These results indicate that
theseedsinguanidine-treated[PSI
+]yeastareinthesamefractionas
thesolublematerialandtherefore,havethesamemolecularweightas
thesolublematerial.Thisinturnimpliesthatthereareapproximately
8 NGMC molecules per seed. Therefore, NGMC seeds are much
smaller in guanidine-treated [PSI
+] yeast than in yeast cured by
overexpression of Hsp104-2KT.
In vitro Studies Measuring the Fraction of NGMC
Monomer in Partially Cured [PSI
+] Yeast
All of the above studies used live cell imaging to study the
properties of NGMC during the curing of [PSI
+] yeast by
inactivation of Hsp104. To further characterize the difference in
prion size during curing by guanidine treatment or by over-
expression of Hsp104-2KT, we examined the properties of
NGMC in yeast lysates prepared from [PSI
+], partially cured,
and [psi
-] yeast. If the seeds are indeed smaller in yeast cured by
guanidine than by overexpression of Hsp104-2KT, we would
expect that more monomer would be present in the yeast partially
cured by guanidine than by overexpression of Hsp104-2KT. We
first examined whether NGMC was in fact monomeric in lysates
from [psi
-] yeast by measuring its diffusion coefficient using FCS;
FCS measurements on a solution of GFP were used as a control.
By fitting the autocorrelation curves in Fig. 8A to a 1-component
fit, dwell times were obtained for the different proteins. A dwell
time of 70 ms was obtained for GFP, which yields a diffusion
coefficient of 94 mm
2 s
-1 for GFP in solution, in agreement with
other studies [36,37]. As expected, the mobility of NGMC in [psi
-]
yeast lysates was slower than that of GFP in solution, with NGMC
having a diffusion coefficient of 110 ms, which yields an apparent
molecular weight consistent with NGMC being a monomer in
solution. Apparently upon lysis of [psi
-] yeast, the NGMC is no
longer in a high molecular weight complex. As expected, the
diffusional mobility of NGMC was an order of magnitude slower
in lysates from [PSI
+] yeast than from [psi
-] yeast.
We next examined lysates prepared from [PSI
+] yeast grown for
5 generations either in 5 mM guanidine or in SGal medium to
induce overexpression of Hsp104-2KT; after 5 generations of
growth these yeast were still [PSI
+]. Following high speed
ultracentrifugation to isolate the soluble pool, Western blot
analysis was used to determine the amount of soluble NGMC in
the supernatants from yeast cured by the two different methods
(Fig. 9A). As expected, there were only trace amounts of NGMC
present in the supernatant fraction from [PSI
+] yeast, whereas
considerably more NGMC was present in the supernatants from
partially cured yeast. Furthermore, there was significantly more
NGMC in the supernatants from yeast partially cured by
guanidine treatment than from yeast partially cured by over-
expression of Hsp104-2KT.
Although lysates from yeast partially cured by guanidine
treatment had a larger soluble pool of NGMC than lysates from
yeast partially cured by overexpression of Hsp104-2KT, it was not
clear whether this soluble fraction contained only monomers, small
oligomers, or a mixture of the two. The aggregation state of the
NGMC in the supernatants was determined using FCS to measure
the diffusional mobility of the NGMC. Fig. 9B shows the
autocorrelation curves of the supernatants from high speed
centrifugation of lysates from yeast partially cured by guanidine
treatment or by overexpression of Hsp104-2KT. After centrifu-
gation, regardless of the method of curing, the autocorrelation
curves yielded a value of 125 ms for NGMC in the supernatants.
Figure 6. Effect of overexpression of Ssa1 on NGMC fluores-
cence and prion propagation in [PSI
+] yeast in the presence and
absence of guanidine. (A) Western blot analysis of Hsp70 expression
levels. The lanes are as follows: lane 1; 1074 with pRS314-GAL1-SSA1 in
SD, lane 2; 1074 with pRS314-GAL1-SSA1 in SGal for 5 generations. The
Pgk1 probed by anti-Pgk1 antibody on the same blot was used as an
internal loading control. (B) Effect of overexpression of Ssa1 on NGMC
fluorescence. Cells of strain 1074 having the empty vector pRS314 were
grown in SGal for 5 generations without (a) and with 5 mM guanidine
(b). Cells having pRS314-GAL1-SSA1 were grown under the same
conditions for 5 generations without (c) and with 5 mM guanidine (d).
(C) Effect of overexpression (o/e) of Ssa1 on [PSI
+] propagation and
curing by guanidine (Gdn). [PSI
+] yeast containing pRS314-GAL1-SSA1
were incubated in SGal in the absence (open squares) or presence of
5 mM guanidine (solid circles). The dotted line shows the curing of
[PSI
+] yeast with empty vector incubated in SGal with 5 mM guanidine.
doi:10.1371/journal.pone.0037692.g006
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-]
cells, the NGMC in the supernatant of partially cured yeast cells is
monomeric. This in turn means more monomer is present in the
supernatant of lysates from cells treated with guanidine than in
lysates from cells overexpressing Hsp104-2KT, which is consistent
with the seeds being smaller in yeast partially cured by guanidine.
All of the above studies on curing [PSI
+] by Hsp104 inactivation
used GFP-labeled Sup35 (NGMC). We next examined whether
native Sup35 protein shows a similar difference in the amount of
soluble Sup35 depending on the method of Hsp104 inactivation.
This was done by growing [PSI
+] yeast strain 779-6A, the parental
strain of 1074, for 6 generations in either SD medium with
guanidine or in SGal medium to induce overexpression of
Hsp104-2KT, at which point the plating assay showed the yeast
were all still [PSI
+]. Western blot analysis of yeast lysates prepared
from these cells was used to determine the total amount of Sup35
in the lysates and the amount in the supernatants after high speed
centrifugation. As expected based on previous observations [22],
the 779-6A [PSI
+] yeast strain showed less soluble Sup35, than the
1074 [PSI
+] yeast strain that expresses NGMC (Fig. 9B).
Nevertheless, there was more than twice as much Sup35 in the
supernatant in lysates from [PSI
+] yeast partially cured by
guanidine than by overexpression of Hsp104-2KT (65% vs.
31%). Therefore, whether or not Sup35 is tagged with GFP,
significantly more soluble Sup35 was present in [PSI
+] yeast
partially cured by guanidine than by overexpression of Hsp104-
2KT. Since both methods show a similar time course of curing, as
was shown previously by Ness et al [16], these results indicate that
the reduction in seed size that occurs during curing of [PSI
+]b y
guanidine is not dependent on the use of GFP-tagged Sup35.
Discussion
In this study, we first established that the NGMC foci were the
seeds responsible for propagating the [PSI
+] prion. Specifically,
regardless of whether Hsp104 was inactivated by guanidine or by
overexpression of Hsp104-2KT, the fraction of [PSI
+] yeast with
NGMC foci directly correlated with the extent of prion curing as
determined by the red/white colony assay. None of the yeast in
growing culture showed large agglomerates of immobilized
NGMC nor was there evidence for dead-end aggregates of
NGMC; whenever cells contained visible NGMC foci, the cells
and their progeny were [PSI
+]. The one exception was yeast that
were left with only one focus when [PSI
+] was cured by
overexpression Hsp104-2KT. This was not a dead-end focus
because when a cell with a single focus was grown overnight in SD
medium a small fraction of its daughter cells were [PSI
+].
Evidently, when these cells were plated, high levels of Hsp104-
2KT were still present for a time in the daughter cells resulting in
the curing of most of these cells, and these cured daughter cells
obscured the limited number of [PSI
+] daughter cells present thus
giving the colony a red appearance.
Figure 7. Autocorrelation curves of NGMC in yeast. FCS measurements are of GFP in [PSI
+] yeast, NGMC in [psi
2] cells, NGMC in [PSI
+] cells, and
NGMC in [PSI
+] cells grown in SGal either for 2 h or 3 generations (g) to overexpress Hsp104-2KT, and NGMC in [PSI
+] cells grown for 3 generations in
SD with 5 mM guanidine (Gdn). Since measurements of the GFP diffusional mobility was not significant different between [psi
2] and [PSI
+] cells, only
the curve obtained with [PSI
+] cells is shown.
doi:10.1371/journal.pone.0037692.g007
Table 2. Soluble Sup35 in [PSI
+] yeast expressing Hsp104-
2KT.
[PSI
+] Hsp104-2KT
Generations 1.8 3.4 5
NGMC 6.3 3.7 5.7 10.1
Pgk1 28.6 20.7 25.1 27.9
fraction NGMC
b 1.0 0.6 0.9 1.6
corrected fraction
NGMC
c
1.0 0.8 1.0 1.7
aProtein intensity of NGMC was quantified using the Odyssey software. Yeast
were cured by overexpression of Hsp104-2KT for the indicated generations. The
fractions were also probed with Pgk1p as a loading control.
bFraction of NGMC was calculated by normalizing the data to the soluble NGMC
in [PSI
+] yeast.
cFraction of NGMC was corrected for Pgk1 levels.
doi:10.1371/journal.pone.0037692.t002
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+] by Hsp104
inactivation is due to inhibition of severing of the prion seeds by
Hsp104, in agreement with the model of Tuite et al. [16,18].
During curing by overexpression of Hsp104-2KT, the number
of foci halved each generation, which shows that severing was
completely inhibited and thus the seeds were diluted out by cell
division. During curing by guanidine treatment, when glucose
deprivation was used to make the NGMC foci apparent, our
data show that severing was not completely inhibited. This
accounts for the extra 2–3 generations it takes to cure [PSI
+]b y
guanidine treatment compared to overexpression of Hsp104-
2KT, as well as the difference between our data and the
theoretical line obtained by halving the number of foci each
generation. It is perhaps not surprising that there is residual
severing activity in the presence of guanidine since in vitro
experiments showed that the ATPase activity of Hsp104 was
not completely inhibited by guanidine [32].
Previously, the Chernoff laboratory observed that NMG
expressed from the SUP35 promoter formed large fluorescent
agglomerates during curing of [PSI
+] by overexpression of
Hsp104-2KT, as well as in a [PSI
+] yeast strain expressing low
levels of Hsp104 [7]. They proposed that the formation of large
agglomerates reduced the ability of the prion to propagate,
perhaps because the agglomerate cannot pass to the daughter cells.
In addition, the Taguchi laboratory reported a transmission defect
when guanidine was used to cure [PSI
+] in yeast expressing NMG
from the GAL1 promoter [20], which probably caused consider-
able overexpression of the NMG. In this latter study, the daughter
cells did not inherit the large NMG foci present in the mother
cells, but instead, became enriched in monomeric NMG and were
cured prior to the mother cells. In contrast, when NMG was
expressed from the SUP35 promoter, which probably induced
lower levels of NMG expression than the GAL1 promoter, the
Chernoff laboratory observed diffuse NMG fluorescence during
curing of [PSI
+] by guanidine [7], in agreement with our
observations on NGMC. The fluorescent properties of NGMC
in [PSI
+] yeast during curing by Hsp104 inactivation was also
examined by the Serio laboratory. By expressing NGMC under
Figure 8. Autocorrelation curves of NGMC in yeast lysates. (A)Diffusion mobility of GFP and NGMC. FCS measurements are of GFP in
phosphate buffered saline and of NGMC in lysates from [psi
2] and [PSI
+] yeast, (B) Diffusional mobility of NGMC was measured in the supernatant
from lysates of [PSI
+] yeast following high speed centrifugation. Lysates were prepared from yeast grown for 5 generations either in SD with 5 mM
guanidine (Gdn) or in SGal to overexpress Hsp104-2KT. GFP standard is included in this graph.
doi:10.1371/journal.pone.0037692.g008
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immobilized when Hsp104 was inactivated either by guanidine
treatment or by overexpression of Hsp104-2KT [19]. The
differences between these various studies may be due to
experimental conditions including the time of curing, the amount
of expression, and the construct that was GFP-labeled.
Studies overexpressing NMG suggest it forms large agglomer-
ates that cannot be significantly reduced in size or transmitted to
daughter cells. With regards to this study, we examined whether
there was a defect in the transmission of the NGMC foci to
daughter cells during curing of [PSI
+] by overexpression of
Hsp104-2KT. Our data clearly show that the foci are transmitted
based on their abundance in the daughter cells relative to the
volume of the mother and daughter cells, as proposed by the
Byrne et. al. model [18]. On the other hand, even in yeast that are
propagating the [PSI
+] prion, Serio’s laboratory has detected
a defect in the transmission of seeds to daughter cells [31]. Several
factors might account for the fact that we do not detect a size bias
in transmission of seeds during the curing that occurs when
Hsp104 activity is reduced. First, in untreated [PSI
+] yeast,
Hsp104 is actively remodeling the seeds, which could make the
seed size heterogeneous, whereas when Hsp104-2KT is over-
expressed, there is no remodeling of the seeds and all the seeds
tend to be large [19]. Just based on diffusion alone, if smaller foci
were present, they would diffuse faster and be more likely to pass
from mother to daughter than larger foci. In addition, the
polarisome might play a role in causing the large foci to be
retained in the mother cell. The polarisome is involved in an
Hsp104-dependent mechanism for transporting misfolded proteins
from the daughter to the mother along actin cables [39]. If the
polarisome plays an important role in yeast with active Hsp104 as
opposed to yeast in which Hsp104 activity is inhibited, it could
cause retention of large foci in the mother cells.
Although the mechanism of curing by inactivation of Hsp104 by
guanidine treatment and by overexpression of Hsp104-2KT was
similar, our data show that the NGMC foci became undetectable
during curing by guanidine treatment. The fact that the NGMC
appeared diffusive during curing by guanidine even though the
cells were still [PSI
+], led us to incorrectly propose that cell division
was not essential for the curing of [PSI
+] [21]. However, even
though the seeds were not visible, we have now shown that the
NGMC foci became readily apparent when the [PSI
+] yeast were
either starved or Hsp104-2KT was overexpressed. Since severing
activity is 80% inhibited in 5 mM guanidine, severing activity
cannot account for all of the seeds becoming undetectable.
Furthermore, when [PSI
+] was cured by overexpression of
Hsp104(K218T) in the presence of guanidine, the curing kinetics
showed severing was completely inhibited, but still the seeds
became undetectable. This again shows that severing is not
causing the absence of detectable foci.
FCS microscopy observations suggested that the loss of
detectable foci in [PSI
+] yeast during curing by guanidine
treatment is due to a reduction in the size of the foci. This
reduction in size is dependent on Hsp104 since yeast in which the
HSP104 gene was conditionally deleted showed prominent
NGMC foci during curing of [PSI
+] both in the absence and
presence of guanidine. Therefore, our data are consistent with
Hsp104 having an activity in the presence of guanidine that
reduces or ‘‘trims’’ the size of the prion seeds without severing
them into new seeds. This trimming activity was also observed
when [PSI
+] was cured by overexpression of Hsp104(K218T),
which contains only a point mutation at the ATPase site of the
NBD1 domain of Hsp104. Apparently, trimming activity removes
Sup35 molecules from the prion seeds, but these released Sup35
molecules do not form a new seed. In fact, a size threshold for
misfolded Sup35 oligomers to propagate new seeds rather than to
dissolve into monomer has been incorporated into previous
models of prion propagation [31,40]. One possibility is that
during trimming, Hsp104 extracts Sup35 molecules from the ends
of the prion fiber, whereas during severing, it extracts Sup35
molecules from the interior of the prion fiber. Therefore, during
trimming from the ends of the amyloid fiber, the released Sup35
oligomers may dissolve into monomer, whereas during severing
a new seed is formed.
Not only does trimming by Hsp104 occur during curing of
[PSI
+] by guanidine, but there is also evidence that trimming
occurs in propagating yeast. When Ssa1 was overexpressed, the
time course of [PSI
+] curing by guanidine treatment was not
affected, but the NGMC foci remained prominent until the yeast
were cured. This shows that SSa1 does not affect severing in the
presence of guanidine even though it markedly reduces trimming.
If trimming also occurs in propagating [PSI
+] yeast, Ssa1 should
have the same effect here, that is, without affecting severing it
should increase the size of the foci. Indeed this is what occurred in
the 1074 yeast strain of propagating [PSI
+] yeast. Ssa1 markedly
increased the size of the foci without curing [PSI
+] even after 20
generations of Ssa1 overexpression. These results are consistent
with inhibition of trimming of prion seeds in [PSI
+] yeast in the
presence of excess Ssa1. As for why the foci are larger in [PSI
+]
yeast with active Hsp104 than in [PSI
+] yeast partially cured by
guanidine, this may occur because as Hsp104 severs the prion
seeds, there may be less Hsp104 available to trim the seeds.
Our proposal that Hsp104 both severs and trims seeds is in
agreement with observations that have been made on other triple-
A ATPases. In mammalian cells, two different triple-A ATPase
proteins, spastin and katinin, are able to both trim and sever
microtubules [41]. However, as part of their trimming activity
these proteins are able to completely depolymerize microtubules,
and if trimming alone were able to completely depolymerize prion
seeds, incubation of [PSI
+] cells in the presence of guanidine would
be expected to cure yeast even if cell division were prevented. Of
course, as we pointed out above, this did not occur in our previous
experiments, suggesting that perhaps the prion core has a special
Figure 9. Western blot analysis of the soluble amount of NGMC
and Sup35 during curing by guanidine or by overexpression of
Hsp104-2KT. (A) Western blot of NGMC in total lysate (T) and
supernatants (S) were from [PSI
+] strain 1074 having pFL39-GAL-
HSP104KT at zero time and after growing for 5 generations either in SD
with guanidine or in SGal. NGMC was probed using an anti-GFP
antibody. (B) Western blot of total lysate (T) and supernatants (S)
samples were from [PSI
+] strain 779-6A having pFL39-GAL-HSP104KT at
zero time and after growing for 6 generations either in SD with
guanidine or in SGal. Sup35 was probed using a polyclonal anti-Sup35
antibody. The percent NGMC in the supernatant indicated under each
sample was corrected using Pgk1 as a loading control. Protein intensity
of NGMC and Pgk1 was quantified using the Odyssey software. Western
blots were performed a minimum of 3 times for each experiment and
representative blots are shown in this figure.
doi:10.1371/journal.pone.0037692.g009
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inactivation of Hsp104 cures [PSI
+] prion, but overexpression of
Hsp104 also cures [2]. Since it has been previously been observed
that during the curing of [PSI
+] by overexpression of Hsp104,
Hsp104 partially solubilizes Sup35 aggregates [42], it may turn out
that the trimming activity of Hsp104 is important for curing by
overexpression of Hsp104.
Supporting Information
Movie S1 Transmission of the prion aggregates NGMC
foci from mother to daughter cell during curing by
Hsp104-2KT overexpression. Cells of 1074 strain having
pFL39-GAL-HSP104KT were grown for 6–7 generations in SGal
and imaged using Zeiss LSM780 confocal microscope. After first
imaging the daughter cell, it was photobleached for 5 s, and then
imaged every second for the next 2 min. More than 20 budding
cells were imaged and a representative one is shown in this movie.
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